Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolan Feng

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Gastrointestinal Cancer|September 6, 2021
Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based StudyTiffany Patterson, Jocelyn Chai, Haocheng Li, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2024
Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center studyJonathan Noujaim, Abha A Gupta, Caroline L Holloway, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2024
Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119]Jonathan Noujaim, Abha A Gupta, Caroline L Holloway, et al.
Oncotarget|October 15, 2016
Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancerXiaolan Feng, Haocheng Li, Elizabeth N Kornaga, et al.
Pediatric Blood & Cancer|May 14, 2025
Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra-Abdominal Sarcoma: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyRebecca J Deyell, Hagit Peretz Soroka, Delaney Sharp, et al.
Cancers|July 29, 2023
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune MicroenvironmentXiaolan Feng, Laurie Tonon, Haocheng Li, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2025
Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) studyCatherine S Weadick, Aisha Alshibany, Michelle Jude Michael, et al.
Cancer Medicine|January 19, 2026
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyTalya Wittmann Dayagi, Hagit Peretz Soroka, Alannah Smrke, et al.
The Journal of Molecular Diagnostics : JMD|April 3, 2022
The Neoantigen Landscape of the Coding and Noncoding Cancer Genome SpaceTammy T Y Lau, Zahra J Sefid Dashti, Emma Titmuss, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Gastrointestinal Cancer|September 6, 2021
Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based StudyTiffany Patterson, Jocelyn Chai, Haocheng Li, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2024
Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center studyJonathan Noujaim, Abha A Gupta, Caroline L Holloway, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2024
Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119]Jonathan Noujaim, Abha A Gupta, Caroline L Holloway, et al.
Oncotarget|October 15, 2016
Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancerXiaolan Feng, Haocheng Li, Elizabeth N Kornaga, et al.
Pediatric Blood & Cancer|May 14, 2025
Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra-Abdominal Sarcoma: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyRebecca J Deyell, Hagit Peretz Soroka, Delaney Sharp, et al.
Cancers|July 29, 2023
Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune MicroenvironmentXiaolan Feng, Laurie Tonon, Haocheng Li, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2025
Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) studyCatherine S Weadick, Aisha Alshibany, Michelle Jude Michael, et al.
Cancer Medicine|January 19, 2026
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyTalya Wittmann Dayagi, Hagit Peretz Soroka, Alannah Smrke, et al.
The Journal of Molecular Diagnostics : JMD|April 3, 2022
The Neoantigen Landscape of the Coding and Noncoding Cancer Genome SpaceTammy T Y Lau, Zahra J Sefid Dashti, Emma Titmuss, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Pageof 9